Yoshio Ootaki1, Takuro Tsukube, Yutaka Okita. 1. Department of Surgery, Division II, Kobe University School of Medicine, 7-5-2 Kusunoki-cho, Chuou-ku, Kobe, 650-0017, Japan.
Abstract
OBJECTIVE: The potential benefits of adynamic cardiomyoplasty remain unclear. We determined whether unstimulated skeletal muscle wrap alone prevents or attenuates progressive left ventricular dilation in a canine model of congestive heart failure produced by repeated intracoronary infusions of doxorubicin. SUBJECTS AND METHODS: 14 dogs were randomized in to 2 groups, 1 undergoing cardiomyoplasty (CMP group) and 1 that did not (CONT group). Intracoronary doxorubicin was administered weekly for 5 weeks to induce heart failure. Hemodynamic data was obtained before infusion and 5 weeks afterward. Echocardiography was done weekly. RESULTS: Significant left ventricular dilation was observed in the CONT group--left ventricular end-diastolic diameter increased from 28.9 +/- 2.7 to 38.5 +/- 3.3 mm (p < 0.05). Significant left ventricular dilation was also observed in the CMP group--left ventricular end-diastolic diameter increased from 28.9 +/- 3.3 to 38.0 +/- 4.2 mm (p < 0.05). Dilation was slower in the CMP group than in the CONT group, however. Ejection fraction decreased from 58.0 +/- 13.8 to 29.9 +/- 13.7% in the CONT group, but was preserved from 56.0 +/- 8.8 to 51.9 +/- 10.3% in the CMP group. CONCLUSIONS: Adynamic cardiomyoplasty reduces ventricular dilation associated with heart failure without exacerbating left ventricular dysfunction.
OBJECTIVE: The potential benefits of adynamic cardiomyoplasty remain unclear. We determined whether unstimulated skeletal muscle wrap alone prevents or attenuates progressive left ventricular dilation in a canine model of congestive heart failure produced by repeated intracoronary infusions of doxorubicin. SUBJECTS AND METHODS: 14 dogs were randomized in to 2 groups, 1 undergoing cardiomyoplasty (CMP group) and 1 that did not (CONT group). Intracoronary doxorubicin was administered weekly for 5 weeks to induce heart failure. Hemodynamic data was obtained before infusion and 5 weeks afterward. Echocardiography was done weekly. RESULTS: Significant left ventricular dilation was observed in the CONT group--left ventricular end-diastolic diameter increased from 28.9 +/- 2.7 to 38.5 +/- 3.3 mm (p < 0.05). Significant left ventricular dilation was also observed in the CMP group--left ventricular end-diastolic diameter increased from 28.9 +/- 3.3 to 38.0 +/- 4.2 mm (p < 0.05). Dilation was slower in the CMP group than in the CONT group, however. Ejection fraction decreased from 58.0 +/- 13.8 to 29.9 +/- 13.7% in the CONT group, but was preserved from 56.0 +/- 8.8 to 51.9 +/- 10.3% in the CMP group. CONCLUSIONS:Adynamic cardiomyoplasty reduces ventricular dilation associated with heart failure without exacerbating left ventricular dysfunction.
Authors: J C Chachques; J P Marino; P Lajos; R Zegdi; N D'Attellis; P Fornes; J N Fabiani; A Carpentier Journal: Eur J Cardiothorac Surg Date: 1997-10 Impact factor: 4.191
Authors: P M McCarthy; R C Starling; J Wong; G M Scalia; T Buda; R L Vargo; M Goormastic; J D Thomas; N G Smedira; J B Young Journal: J Thorac Cardiovasc Surg Date: 1997-11 Impact factor: 5.209
Authors: L F Moreira; N A Stolf; E A Bocchi; A C Pereira-Barretto; J C Meneghetti; M C Giorgi; A V Moraes; J J Leite; P L da Luz; A D Jatene Journal: Circulation Date: 1990-11 Impact factor: 29.690
Authors: E R Capouya; R S Gerber; D C Drinkwater; J M Pearl; J B Sack; A S Aharon; S W Barthel; E M Kaczer; P A Chang; H Laks Journal: Ann Thorac Surg Date: 1993-10 Impact factor: 4.330